SCHEMBL7527993

SCHEMBL7527993

CNS(=O)(=O)Cc1ccc(-n2cc(Cc3cncnc3)c(=O)[nH]c2=S)cc1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.38
PLA2G7 Q13093 4/20 0.35
MAPT P10636 1/20 0.31
MET P08581 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7004505 0.81 PLA2G7 (0.38) PLA2G7MAPT
SCHEMBL7007975 0.80 KMT2A (0.40) PLA2G7MAPT
SCHEMBL7011218 0.79 PLA2G7 (0.44) PLA2G7
SCHEMBL7012920 0.79 PLA2G7 (0.44) PLA2G7
SCHEMBL7529761 0.76 PLA2G7 (0.41) PLA2G7MAPT
SCHEMBL7530971 0.76 ALDH1A1 (0.43) MAPT
SCHEMBL7011062 0.72 PLA2G7 (0.46) PLA2G7
SCHEMBL7011203 0.71 PLA2G7 (0.41) PLA2G7
SCHEMBL7010646 0.70 PLA2G7 (0.39) PLA2G7
SCHEMBL7013475 0.70 PLA2G7 (0.39) PLA2G7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1175409-A1 PYRIMIDINONES DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 2002-01-30 EP disclosed
WO-2000068208-A1 PYRIMIDINONES DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 2000-11-16 WO disclosed